The Voice of the Industry
With our vast experience and expertise, Cryoport Systems is proud to be featured in reputable industry publications. Our subject matter experts offer their insights and input into life sciences topics in these articles.
07/08/2024
Cryoport Systems: Leading the Way in Quality and Commitment to Excellence
Cryoport Systems commemorated the significant expansion of its Pont-du-Château facility in France with a ribbon cutting ceremony that officially launched the updated site.06/18/2024
Cryoport Systems Officially Launches Global Supply Chain Hub in Stevenage, U.K.
Cryoport Systems is excited to announce the significant expansion of its Pont-du-Château facility in France.06/12/2024
Cryoport Systems Announces Major Expansion of Pont-du-Château Facility and Official Rebrand of Cell&Co
Cryoport Systems is excited to announce the significant expansion of its Pont-du-Château facility in France.06/12/2024
Cryoport, Inc. Receives 5 Nominations for APCGTEA 2024
Cryoport, Inc. is thrilled to receive five prestigious nominations for the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2024!03/22/2024
Cryoport Systems Talks Leveraging Supply Chain Visibility Technologies with Pharmaceutical Outsourcing
Strong visibility into your advanced medicine supply chain is necessary to meet the life sciences industry’s strict quality requirements and maintain therapy viability.03/15/2024
0% Failure Rate: Our Support of Certainty Featured by gasworld
Mark Sawicki, Cryoport Systems’ Chief Executive Officer, recently explained how Cryoport Systems operates on a 0% failure rate to support the complex and ever-evolving life sciences industry.11/27/2023
Uniting a Cell and Gene Kingdom in Article with the Medicine Maker
Both Cryoport Systems’ own Robert Jones, Vice President of Global BioServices, and Mark Sawicki, President, CEO, and Chief Scientific Officer, shared details of our recently announced...07/10/2023
Location, infrastructure boost NJ’s biotech, life sciences industries
NJBIZ interviewed Cryoport Systems’ CEO, Mark Sawicki, about Cryoport Systems’ expansion into BioServices and our Morris Plains, NJ facility location in an article...04/27/2023
Standardize for Success with Mark Sawicki for The Medicine Maker
Dr. Mark Sawicki, Cryoport System’s CEO, shared his expertise on the future of regenerative medicine and the top challenges facing the industry today with The Medicine Maker.01/18/2023
New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, Inc. is excited to announce a new strategic partnership with Syneos Health, a fully integrated biopharmaceutical solutions organization.12/02/2022
Life Sciences Review Awards MVE Bio The Top Clinical Lab Equipment Company
A salient aspect of biological research concerns collecting and preserving biological samples and materials for analysis. Since samples often degrade in the time between collection and analysis...07/01/2022
Cryoport and Cell Matters Collaboration Aids in the Standardization of Cell Therapy Supply Chain Processes
A salient aspect of biological research concerns collecting and preserving biological samples and materials for analysis. Since samples often degrade in the time between collection and analysis...06/30/2022
RegMedNet Highlights Cryoport’s First Two Global Supply Chain Centers
Cryoport Systems' first two Global Supply Chain Centers in Morris Plains, New Jersey and Houston, Texas will provide critical support to major biotech companies around the world...04/27/2022
Cryoport Expands Global Supply Chain Network through Recent Acquisition of Cell&Co BioServices
The recent acquisition of of Cell&Co BioServices by Cryoport, Inc. will help to expand global service offerings by generating opportunities for clinical trial and cell and gene therapy developers in Europe.04/23/2022